ロード中...
Selective delivery of T22-PE24-H6 to CXCR4(+) diffuse large B-cell lymphoma cells leads to wide therapeutic index in a disseminated mouse model
Background: Novel therapeutic strategies are urgently needed to reduce relapse rates and enhance survival in Diffuse Large B-Cell Lymphoma (DLBCL) patients. CXCR4-overexpressing cancer cells are good targets for therapy because of their association with dissemination and relapse in R-CHOP treated DL...
保存先:
| 出版年: | Theranostics |
|---|---|
| 主要な著者: | , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Ivyspring International Publisher
2020
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7196303/ https://ncbi.nlm.nih.gov/pubmed/32373205 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.43231 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|